Clinical trial · Observational
Safe, Effective, and More Tolerable 16 Tablets Colon Prep
Phase III of the AB Prep Safety and Efficacy in Colon Cleansing
NCT00817934CI-TRIAL-00001871ABPunknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is determine if the AB Prep (a 16 tablets colon cleansing prep), is an effective, and safe colon cleansing prep in preparation for colonoscopy, and severe constipation.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Colon Cancer | Malignant Colon Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| AB PREP | Drug | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- PREVENTION AND TREATMENT
- description
- PATIENTS 50 YEARS AND OLDER REQUIRE SCREENING COLONOSCOPY. PATIENTS WITH FAMILY HISTORY OF COLON CANCER WILL REQUIRE IT BEFORE THE AGE OF 50.
- interventionNames
- Drug: AB PREP
Primary outcomes (1)
- measure
- TOTAL COLON CLEANSING, TO BE ABLE TO PERFORM COLONOSCOPY
- timeFrame
- IMMEDIATE, DURING THE COLONOSCOPY
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 12 Years
- Maximum age
- 75 Years
Show eligibility criteria text
Inclusion Criteria: * Any eligible patient for colonoscopy Exclusion Criteria: * Patients with renal failure
References
Publications (0)
Data not yet available
No reference posted for this study.